Search by Drug Name or NDC
NDC 50090-4968-00 Benzonatate 100 mg/1 Details
Benzonatate 100 mg/1
Benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 50090-4968-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 50090-4968 |
|---|---|
| Product ID | 50090-4968_307aec37-9f24-4b15-84e0-c679d4d26643 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Benzonatate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benzonatate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202765 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4968-00 (50090496800)
| NDC Package Code | 50090-4968-0 |
|---|---|
| Billing NDC | 50090496800 |
| Package | 15 CAPSULE in 1 BOTTLE (50090-4968-0) |
| Marketing Start Date | 2021-09-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |